AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOPHARMA CREDIT PLC

Board/Management Information Mar 22, 2023

4973_rns_2023-03-22_5f26c9da-b425-41a9-80d5-f79d8f8d88dc.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7785T

BioPharma Credit PLC

22 March 2023

BIOPHARMA CREDIT PLC 

(THE "COMPANY")

Appointment of New Director

The Company is pleased to announce the appointment of Sapna Shah as a non-executive Director, with effect from 22 March 2023.

Ms Shah has 20 years of investment banking experience advising UK companies, including listed REITs and investment companies, on IPOs, equity capital market transactions and mergers and acquisitions. Ms Shah is a non-executive Director of Supermarket Income REIT plc and a non-executive Director and remuneration committee member of The Association of Investment Companies ("AIC"). Ms Shah is a Senior Adviser at Panmure Gordon Limited and prior to this held senior investment banking roles at UBS AG, Oriel Securities (now Stifel Nicolaus Europe) and Cenkos Securities. She has previously served on the advisory committee for a private solar energy company.

Publicly quoted directorships held by Ms Shah within the last five years are as follows:

Company Position
Supermarket Income REIT PLC Non-executive Director

There are no other details required to be disclosed under LR 9.6.13R (2) to (6) of the Financial Conduct Authority Listing Rules.

22 March 2023

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAKZGZFLMMGFZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.